Literature DB >> 10486356

Simultaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure.

M Matsuoka1, Y Yoshida, K Hayakawa, S Fukuchi, K Sugano.   

Abstract

BACKGROUND: It was recently reported that A to G transition mutations at positions 2143 and 2144 in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori. AIMS: To study the incidence and mechanism of development of clarithromycin resistance by analysing these mutations.
SUBJECTS: Eighty two H pylori positive patients who had an endoscopic examination and no history of treatment with macrolide antibiotics.
METHODS: Clarithromycin resistance was screened for by polymerase chain reaction-restriction fragment length polymorphism of the 23S rRNA gene coupled with antibiotic susceptibility testing. In clinical isolates with mutations or resistance, mutations in individual colonies were analysed by direct sequencing.
RESULTS: Of the 79 amplicons (DNA fragments amplified by polymerase chain reaction), Alw26I and MboII digestion disclosed the mutation in four (5%) and one (1%) respectively. However, the Alw26I cleavage was incomplete in two of the four amplicons, as was the MboII cleavage. Individual colony analysis of the isolates with incomplete cleavage patterns showed the presence of both wild type and mutated strains in the 23S rRNA genes.
CONCLUSIONS: Both clarithromycin sensitive and resistant strains colonised in some patients with no history of exposure to macrolides. The results suggest that resistant strains may not be formed but selected by clarithromycin administration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486356      PMCID: PMC1727681          DOI: 10.1136/gut.45.4.503

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients.

Authors:  K Hultén; A Gibreel; O Sköld; L Engstrand
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

2.  Detection and identification of Helicobacter pylori by the polymerase chain reaction.

Authors:  C Clayton; K Kleanthous; S Tabaqchali
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

3.  Multiple strain colonization and metronidazole resistance in Helicobacter pylori-infected patients: identification from sequential and multiple biopsy specimens.

Authors:  M Jorgensen; G Daskalopoulos; V Warburton; H M Mitchell; S L Hazell
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

4.  Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori.

Authors:  G G Stone; D Shortridge; R K Flamm; J Versalovic; J Beyer; K Idler; L Zulawinski; S K Tanaka
Journal:  Helicobacter       Date:  1996-12       Impact factor: 5.753

5.  Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori.

Authors:  Y J Debets-Ossenkopp; M Sparrius; J G Kusters; J J Kolkman; C M Vandenbroucke-Grauls
Journal:  FEMS Microbiol Lett       Date:  1996-08-15       Impact factor: 2.742

6.  Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes.

Authors:  A Occhialini; M Urdaci; F Doucet-Populaire; C M Bébéar; H Lamouliatte; F Mégraud
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

7.  Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Authors:  J Versalovic; D Shortridge; K Kibler; M V Griffy; J Beyer; R K Flamm; S K Tanaka; D Y Graham; M F Go
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

8.  Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.

Authors:  P Moayyedi; P Sahay; D S Tompkins; A T Axon
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-09       Impact factor: 2.566

9.  Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection.

Authors:  M M Yousfi; H M el-Zimaity; M T al-Assi; R A Cole; R M Genta; D Y Graham
Journal:  Aliment Pharmacol Ther       Date:  1995-04       Impact factor: 8.171

10.  Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA.

Authors:  D Moazed; H F Noller
Journal:  Biochimie       Date:  1987-08       Impact factor: 4.079

View more
  15 in total

1.  Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium.

Authors:  M Matsumura; Y Hikiba; K Ogura; G Togo; I Tsukuda; K Ushikawa; Y Shiratori; M Omata
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Helicobacter pylori in children: acquisition of antimicrobial resistance after an initial course of treatment.

Authors:  N Kalach; P H Benhamou; C Dupont; J Raymond; M Bergeret; F Gottrand; M O Husson
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori.

Authors:  Christophe Burucoa; Cédric Landron; Martine Garnier; Jean-Louis Fauchère
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Antibiotic resistance of Helicobacter pylori strains in Japanese children.

Authors:  Seiichi Kato; Shigeru Fujimura; Hirokazu Udagawa; Toshiaki Shimizu; Shunichi Maisawa; Kyoko Ozawa; Kazuie Iinuma
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Characterisation of the genes encoding resistance to metronidazole (rdxA and frxA) and clarithromycin (the 23S-rRNA genes) in South African isolates of Helicobacter pylori.

Authors:  N F Tanih; L M Ndip; R N Ndip
Journal:  Ann Trop Med Parasitol       Date:  2011-04

6.  Clarithromycin-susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy.

Authors:  A van der Ende; L J van Doorn; S Rooijakkers; M Feller; G N Tytgat; J Dankert
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

7.  Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea.

Authors:  Jung Mogg Kim; Joo Sung Kim; Hyun Chae Jung; Nayoung Kim; Young-Jeon Kim; In Sung Song
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

Review 8.  Basis for the management of drug-resistant Helicobacter pylori infection.

Authors:  Francis Mégraud
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori.

Authors:  Norazah Ahmad; Wan-Rasinah Zakaria; Sheikh-Anwar Abdullah; Ramelah Mohamed
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

10.  Analysis of Helicobacter pylori genotypes in clinical gastric wash samples.

Authors:  Shuichi Miyamoto; Yoshiyuki Watanabe; Ritsuko Oikawa; Shoko Ono; Katsuhiro Mabe; Takahiko Kudo; Hiroyuki Yamamoto; Fumio Itoh; Mototsugu Kato; Naoya Sakamoto
Journal:  Tumour Biol       Date:  2016-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.